NetworkNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Enters Strategic Collaboration to Explore Innovative Products and Medical Solutions

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced its entry into a cooperation agreement with Roche Pharmaceuticals China (“Roche”) to leverage both parties’ advantages and sources to explore novel health care and medical solutions and collaboration models in early cancer screening, early diagnosis and early treatment. According to the update, AnPac Bio and Roche will jointly explore personalized product lines and solutions and will target the general population for early cancer screening, hospital diagnosis, and precision medicine through therapy selection testing. The synergistic collaboration plans to form a competitive package of products and services to enhance cancer screening and follow-up tests, improve customers’ affordability, and help customers to receive more innovative, affordable and high-quality health care and medical services.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer